Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



SULIMAN SHEHNAAZ Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 SULIMAN SHEHNAAZ (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Granted 1,865 shares @ $0
Granted 4,661 options to buy @ $57.62, valued at $268.6k
06/09/2023 4 SULIMAN SHEHNAAZ (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,860 shares @ $0
Granted 7,110 options to buy @ $51.82, valued at $368.4k
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/14/2021 4 SULIMAN SHEHNAAZ (President and COO) has filed a Form 4 on Alector, Inc.
Txns: Sold 66,126 shares @ $21.6855, valued at $1.4M
Sold 8,874 shares @ $22.334, valued at $198.2k
Sold 64,102 shares @ $21.1592, valued at $1.4M
Sold 10,898 shares @ $21.7289, valued at $236.8k
Exercised 75,000 options to buy @ $17.23, valued at $1.3M
Exercised 75,000 options to buy @ $17.23, valued at $1.3M
12/10/2021 4 SULIMAN SHEHNAAZ (President and COO) has filed a Form 4 on Alector, Inc.
Txns: Sold 36,511 shares @ $22.5583, valued at $823.6k
Sold 38,489 shares @ $23.0115, valued at $885.7k
Sold 72,357 shares @ $22.8034, valued at $1.6M
Sold 2,643 shares @ $23.4043, valued at $61.9k
Exercised 19,813 options to buy @ $17.23, valued at $341.4k
Exercised 55,187 options to buy @ $10.24, valued at $565.1k
Exercised 75,000 options to buy @ $17.23, valued at $1.3M
06/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2021 4 SULIMAN SHEHNAAZ (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Granted 625 shares @ $0
Granted 1,563 options to buy @ $193.51, valued at $302.5k
05/11/2021 4 SULIMAN SHEHNAAZ (President and COO) has filed a Form 4 on Alector, Inc.
Txns: Granted 100,000 shares @ $0
10/05/2020 4 SULIMAN SHEHNAAZ (President and COO) has filed a Form 4 on Alector, Inc.
Txns: Granted 189,213 options to buy @ $10.24, valued at $1.9M
06/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2020 4 SULIMAN SHEHNAAZ (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Granted 4,432 options to buy @ $88.42, valued at $391.9k
01/27/2020 4 SULIMAN SHEHNAAZ (President and COO) has filed a Form 4 on Alector, Inc.
Txns: Granted 550,000 options to buy @ $17.23, valued at $9.5M
09/16/2019 4 SULIMAN SHEHNAAZ (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Disposed of 100,000 options to buy @ $30, valued at $3M
Acquired 100,000 options to buy @ $30, valued at $3M
06/13/2019 4 SULIMAN SHEHNAAZ (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,000 shares @ $0
Granted 5,000 options to buy @ $58.74, valued at $293.7k
02/22/2019 4 SULIMAN SHEHNAAZ (SVP, Corp Dev & Strategy) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 5,763 shares @ $27, valued at $155.6k
02/01/2019 4 SULIMAN SHEHNAAZ (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 20,000 options to buy @ $48.85, valued at $977k
02/22/2018 4 SULIMAN SHEHNAAZ (SVP, Corp Dev & Strategy) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 8,770 shares @ $29.09, valued at $255.1k
02/14/2018 4 SULIMAN SHEHNAAZ (SVP, Corp Dev & Strategy) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 65,000 shares @ $0
Granted 25,000 shares @ $0
08/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy